Artículo original
Respuesta a ranibizumab en pacientes con degeneración macular húmeda con tracción vitreomacular
Responses to ranibizumab in wet age-related macular degeneration patients with vitreomacular traction
A. Filloy
, L. Arias
Autor para correspondencia
Servicio de Oftalmología, Hospital Universitari de Bellvitge-Institut d’Investigació Biomèdica de Bellvitge, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, España
Leído
1739
Vecesse ha leído el artículo
323
Total PDF
1416
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2023 3 | 2 | 3 | 5 |
| 2020 1 | 1 | 0 | 1 |
| 2018 2 | 12 | 2 | 14 |
| 2018 1 | 13 | 0 | 13 |
| 2017 12 | 15 | 1 | 16 |
| 2017 11 | 14 | 0 | 14 |
| 2017 10 | 21 | 2 | 23 |
| 2017 9 | 13 | 4 | 17 |
| 2017 8 | 5 | 0 | 5 |
| 2017 7 | 16 | 2 | 18 |
| 2017 6 | 11 | 5 | 16 |
| 2017 5 | 25 | 1 | 26 |
| 2017 4 | 34 | 7 | 41 |
| 2017 3 | 27 | 10 | 37 |
| 2017 2 | 20 | 3 | 23 |
| 2016 1 | 17 | 0 | 17 |
| 2016 12 | 35 | 5 | 40 |
| 2016 11 | 42 | 3 | 45 |
| 2016 10 | 47 | 17 | 64 |
| 2016 9 | 76 | 9 | 85 |
| 2016 8 | 44 | 5 | 49 |
| 2016 7 | 28 | 6 | 34 |
| 2016 6 | 35 | 22 | 57 |
| 2016 5 | 27 | 6 | 33 |
| 2016 4 | 35 | 7 | 42 |
| 2016 3 | 26 | 9 | 35 |
| 2016 2 | 34 | 8 | 42 |
| 2015 1 | 33 | 14 | 47 |
| 2015 12 | 31 | 14 | 45 |
| 2015 11 | 27 | 2 | 29 |
| 2015 10 | 36 | 8 | 44 |
| 2015 9 | 24 | 5 | 29 |
| 2015 8 | 46 | 4 | 50 |
| 2015 7 | 39 | 5 | 44 |
| 2015 6 | 15 | 6 | 21 |
| 2015 5 | 34 | 5 | 39 |
| 2015 4 | 32 | 10 | 42 |
| 2015 3 | 47 | 16 | 63 |
| 2015 2 | 15 | 4 | 19 |
| 2015 1 | 20 | 8 | 28 |
| 2014 12 | 39 | 17 | 56 |
| 2014 11 | 29 | 5 | 34 |
| 2014 10 | 57 | 5 | 62 |
| 2014 9 | 42 | 9 | 51 |
| 2014 8 | 30 | 6 | 36 |
| 2014 7 | 32 | 9 | 41 |
| 2014 6 | 32 | 8 | 40 |
| 2014 5 | 51 | 10 | 61 |
| 2014 4 | 27 | 10 | 37 |
| 2013 11 | 0 | 3 | 3 |
| 2013 10 | 3 | 0 | 3 |
| 2013 9 | 0 | 3 | 3 |
Mostrar todo
